Vaccine Technology IV

Co-Chairs: Paula M. Alves IBET/ITQB Portugal John G. Auniņš Jānis Biologics, LLC USA Barry C. Buckland University College London UK Kathrin U. Jansen Pfizer USA Session Topics: Vaccine Target Identification and Validation Session co-chairs: George Siber, Genocea, USA David Weiner, University of Pennsylvania, USA Bioprocess Development and Analytical Tools Session co-chairs: Luis Maranga, Novartis Vaccines & Diagnostics, Inc., USA Mike Washabaugh, Astra Zeneca, USA Late Stage and Recently Launched Vaccines Session co-chairs Nathalie Garçon, GlaxoSmithKline, Belgium Kathrin Jansen, Pfizer, USA Veterinary Vaccines Session co-chairs: Robert Nordgren, Merial, USA/France Ian Tarpey, Merck Animal Health, UK New Technologies and Approaches Session co-chairs: Mike Hoare, University College London, UK Herve Pinton, Sanofi Pasteur, France Technology Challenges in the Developing World Session co-chairs: Leda Castilho, Federal Univ. of Rio de Janeiro, Brasil Paula Alves, Instituto Biologia Experimental e Tecnologica, Portugal  Oncology and Therapeutic Vaccines Session co-chairs: John G. Auniņš, Jānis Biologics LLC, USA Amine Kamen, Biotechnology Research Institute, National Research Council of Canada Biodefense, Pandemic and Emerging Disease Vaccines Session co-chairs: Barry Buckland, University College, London, UK Phil Gomez, Price Waterhouse Coopers, USA Vaccine Stability, Characterization and Delivery? Session co-chairs: Debbie Drane, CSL Limited, Australia Robert Evans, Merck Sharp & Dohme Research Laboratories, USA Laura Palomares, Universidade Nacional Autonomous de Mexico Confirmed Keynote Speakers Julie Gerberding, Merck Sharp & Dohme, USA Stephen Russell, Mayo Clinic, USA Poster Chairs: Tarit K. Mukhopadhyay, University College London, UK Hela Kallel, Institute Pasteur in Tunis, Tunisia